Relugolix

• Description:

  Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH) ) antagonist, with potential antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  623.63

• Molecular Formula:

  C29H27F2N7O5S

• Notes:

  Research use only, not for human use.

• Receptor:

  GNRHR

• CAS Number:

  737789-87-6